Related Experiment Videos
A phase II investigation of pentostatin in metastatic malignant melanoma
Investigational New Drugs
|November 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
New antineoplastic aza-phospholipids - synthesis, in-vitro cytotoxicity and differential cellular-sensitivity against 70 human tumor-cell lines.
International journal of oncology·2011
Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology·2008
Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
Clinical cancer research : an official journal of the American Association for Cancer Research·1999
Parthenolide enhances imatinib activity in gastrointestinal stromal tumor models through stress-associated apoptosis.
Investigational new drugs·2026
First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.
Investigational new drugs·2026
Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer.
CPT: pharmacometrics & systems pharmacology·2026
The Future of all-Comers Trials in the Era of Precision Oncology.
Clinical pharmacology and therapeutics·2026
MyoD and Myogenin regulatory cascade is targeted by tumor signals to repress myogenesis in cancer cachexia.
The Biochemical journal·2026
Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).
Journal of Alzheimer's disease : JAD·2026
Conferone: Sources, Anticancer Mechanisms, and Potential in Overcoming Chemoresistance - A Comprehensive Review.
Current pharmaceutical design·2026